• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因手术血运重建被拒绝的患者经皮冠状动脉介入治疗的临床结果

Clinical outcomes of percutaneous coronary intervention in patients turned down for surgical revascularization.

作者信息

Sukul Devraj, Seth Milan, Dixon Simon R, Zainea Mark, Slocum Nicklaus K, Pielsticker Elizabeth J, Gurm Hitinder S

机构信息

Division of Cardiovascular Medicine, Department of Medicine, University of Michigan, Ann Arbor, Michigan.

Division of Cardiology, Department of Medicine, Beaumont Hospital, Royal Oak, Michigan.

出版信息

Catheter Cardiovasc Interv. 2017 Jul;90(1):94-101. doi: 10.1002/ccd.26781. Epub 2016 Sep 21.

DOI:10.1002/ccd.26781
PMID:27651035
Abstract

OBJECTIVES

We examined clinical outcomes following percutaneous coronary intervention (PCI) in patients turned down for surgical revascularization across a broad population.

BACKGROUND

Prior studies suggest that surgical ineligibility is associated with increased mortality in patients with unprotected left main or multivessel coronary artery disease undergoing PCI.

METHODS

This study included consecutive patients who underwent PCI in a multicenter registry in Michigan from January 2010 to December 2014. Surgical ineligibility required documentation indicating that a cardiac surgeon deemed the patient ineligible for surgery. In-hospital outcomes included mortality (primary outcome), cardiogenic shock, cerebrovascular accident, contrast-induced nephropathy (CIN), and a new requirement for dialysis (NRD).

RESULTS

Of 99,370 patients at 33 hospitals with on-site surgical backup, 1,922 (1.9%) were surgically ineligible. The rate of ineligibility did not vary by hospital (range: 1.5-2.5%; P = 0.79). Overall, there were no major differences in baseline characteristics or outcomes between surgically ineligible patients and the rest (i.e., nonineligible patients): mortality (0.52% vs. 0.52%; P > 0.5), cardiogenic shock (0.68% vs. 0.73%; P > 0.5), cerebrovascular accident (0.05% vs. 0.19%; P = 0.28), NRD (0.16% vs. 0.19%; P > 0.5), CIN (2.7% vs. 2.3%; P = 0.27). Among 1,074 patients who underwent unprotected left main PCI, 20 (1.9%) were surgically ineligible and experienced increased rates of mortality (20.0% vs. 5.3%; P = 0.022; adjusted OR = 7.38; P < 0.001) and other complications as compared to the remainder.

CONCLUSIONS

PCI in a broad population of surgically ineligible patients is generally safe. However, among patients who underwent unprotected left main PCI, those deemed surgically ineligible experienced significantly worse outcomes as compared to the rest. © 2016 Wiley Periodicals, Inc.

摘要

目的

我们在广泛人群中研究了经皮冠状动脉介入治疗(PCI)在因手术血运重建被拒的患者中的临床结局。

背景

先前的研究表明,在接受PCI的无保护左主干或多支冠状动脉疾病患者中,手术禁忌与死亡率增加相关。

方法

本研究纳入了2010年1月至2014年12月在密歇根州一个多中心登记处接受PCI的连续患者。手术禁忌需要有文件表明心脏外科医生认为该患者不适合手术。住院结局包括死亡率(主要结局)、心源性休克、脑血管意外、造影剂肾病(CIN)以及新的透析需求(NRD)。

结果

在33家有现场手术支持的医院的99,370例患者中,1,922例(1.9%)不适合手术。不适合手术的比例在各医院之间没有差异(范围:1.5 - 2.5%;P = 0.79)。总体而言,不适合手术的患者与其余患者(即适合手术的患者)在基线特征或结局方面没有重大差异:死亡率(0.52%对0.52%;P > 0.5)、心源性休克(0.68%对0.73%;P > 0.5)、脑血管意外(0.05%对0.19%;P = 0.28)、NRD(0.16%对0.19%;P > 0.5)、CIN(2.7%对2.3%;P = 0.27)。在1,074例接受无保护左主干PCI的患者中,20例(1.9%)不适合手术,与其余患者相比,死亡率(20.0%对5.3%;P = 0.022;调整后的OR = 7.38;P < 0.001)和其他并发症发生率更高。

结论

在广泛的不适合手术的患者群体中进行PCI总体上是安全的。然而,在接受无保护左主干PCI的患者中,那些被认为不适合手术的患者与其余患者相比结局明显更差。© 2016威利期刊公司

相似文献

1
Clinical outcomes of percutaneous coronary intervention in patients turned down for surgical revascularization.因手术血运重建被拒绝的患者经皮冠状动脉介入治疗的临床结果
Catheter Cardiovasc Interv. 2017 Jul;90(1):94-101. doi: 10.1002/ccd.26781. Epub 2016 Sep 21.
2
Nonemergent Percutaneous Coronary Intervention on an Unprotected Left Main Coronary Artery Supported with Impella® Heart Pump in Patients Ineligible for Surgical Revascularization.对不适合外科血运重建的患者,使用 Impella® 心脏泵支持的非紧急经皮冠状动脉介入治疗无保护左主干冠状动脉。
J Interv Cardiol. 2019 Jun 4;2019:9691753. doi: 10.1155/2019/9691753. eCollection 2019.
3
Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention.接受经皮冠状动脉介入治疗的无保护左主干或多支冠状动脉疾病患者的手术禁忌和死亡率
Circulation. 2014 Dec 23;130(25):2295-301. doi: 10.1161/CIRCULATIONAHA.114.011541. Epub 2014 Nov 12.
4
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.DELTA 注册研究:非保护左主干冠状动脉开口/中段病变行经皮冠状动脉介入治疗与冠状动脉旁路移植术的长期临床结果:多中心注册研究评估左主干病变的经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗
JACC Cardiovasc Interv. 2014 Apr;7(4):354-61. doi: 10.1016/j.jcin.2013.11.014. Epub 2014 Mar 14.
5
Surgical Ineligibility and Long-Term Outcomes in Patients With Severe Coronary Artery Disease.严重冠状动脉疾病患者的手术不合格和长期结果。
Circ J. 2019 Sep 25;83(10):2061-2069. doi: 10.1253/circj.CJ-19-0440. Epub 2019 Aug 22.
6
Percutaneous coronary intervention or coronary artery bypass grafting for unprotected left main coronary artery disease.经皮冠状动脉介入治疗或冠状动脉旁路移植术治疗无保护左主干冠状动脉疾病。
Catheter Cardiovasc Interv. 2017 Oct 1;90(4):541-552. doi: 10.1002/ccd.26970. Epub 2017 Mar 15.
7
Outcomes Following Percutaneous Coronary Intervention in Patients With Multivessel Disease Who Were Recommended for But Declined Coronary Artery Bypass Graft Surgery.多支血管病变患者行冠状动脉介入治疗后结局:推荐行冠状动脉旁路移植术,但患者拒绝。
J Am Heart Assoc. 2024 Jun 4;13(11):e033931. doi: 10.1161/JAHA.123.033931. Epub 2024 May 31.
8
The impact of previous revascularization on clinical outcomes in patients undergoing primary percutaneous coronary intervention.既往血运重建对接受直接经皮冠状动脉介入治疗患者临床结局的影响。
J Invasive Cardiol. 2013 Apr;25(4):166-9.
9
Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.经皮冠状动脉介入治疗开口/中段病变与无保护左主干冠状动脉分叉病变的长期临床结局:DELTA 注册研究(左主干冠状动脉疾病药物洗脱支架):一项多中心注册研究,评估经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左主干的疗效。
JACC Cardiovasc Interv. 2013 Dec;6(12):1242-9. doi: 10.1016/j.jcin.2013.08.005.
10
A comparative study of bypass versus percutaneous intervention for left main disease.左主干病变搭桥术与经皮介入治疗的对比研究。
Tunis Med. 2019 Apr;97(4):533-540.

引用本文的文献

1
Mortality After Multivessel Revascularization in Patients With Diabetes and Acute Coronary Syndromes.糖尿病合并急性冠脉综合征患者多支血管血运重建后的死亡率
JACC Adv. 2024 Sep 18;3(9):101203. doi: 10.1016/j.jacadv.2024.101203. eCollection 2024 Sep.
2
A Review of the Impella Devices.Impella设备综述
Interv Cardiol. 2022 Apr 8;17:e05. doi: 10.15420/icr.2021.11. eCollection 2022 Jan.
3
Surgical Turned-Downed CHIP Cases-Can PCI Save the Day?手术拒绝的CHIP病例——PCI能挽救局面吗?
Front Cardiovasc Med. 2022 Apr 7;9:872398. doi: 10.3389/fcvm.2022.872398. eCollection 2022.
4
Nonemergent Percutaneous Coronary Intervention on an Unprotected Left Main Coronary Artery Supported with Impella® Heart Pump in Patients Ineligible for Surgical Revascularization.对不适合外科血运重建的患者,使用 Impella® 心脏泵支持的非紧急经皮冠状动脉介入治疗无保护左主干冠状动脉。
J Interv Cardiol. 2019 Jun 4;2019:9691753. doi: 10.1155/2019/9691753. eCollection 2019.